• Home
  • |
  • Contact
  • Add to Favorites
  • |
  • Stay up to Date
  • |
  • Tell a Colleague
  • |
  • Send us your Feedback
Skip navigation links
HOME
ABOUT EMAS
MEETINGS
MEMBERSHIP
EDUCATION
MEDIA
PATIENTS
ARCHIVES
WHO WE ARE
PRESIDENT'S LETTER
EMAS GOVERNING BOARD
EMAS ARTICLES OF ASSOCIATION
HOW TO JOIN EMAS
EMAS CORPORATE MEMBERS
AFFILIATED SOCIETIES
CONTACT US
Scroll up
Scroll down
EMAS CONGRESSES
MEETINGS & EVENTS
PRESENTATIONS FROM LONDON
Scroll up
Scroll down
EMAS MEMBER BENEFITS
MEMBERSHIP UPDATE FORM
MEMBERSHIP APPLICATION FORM
MEMBERSHIP RENEWAL FORM
Scroll up
Scroll down
MATURITAS JOURNAL
EMAS PRESENTATIONS
EMAS POSITION STATEMENTS & RECOMMENDATIONS
EMAS CLINICAL UPDATES
FAQ
LINKS
Scroll up
Scroll down
EMAS PRESS RELEASES
Scroll up
Scroll down
INFORMATION ABOUT MENOPAUSE
WEB RESOURCES
PARTICIPATE IN RESEARCH STUDIES
REFERRAL LISTS
Scroll up
Scroll down
PPT PRESENTATIONS
ARTICLES
MENOPAUSE BOOKS
CONFERENCE INTERVIEWS
Scroll up
Scroll down
The European Menopause and Andropause Society

 


 

 

 EDUCATIONAL MATERIALS 

2006 | 2008 | 2009 | 2010

2010 

 

HRT & CHD is there evidence for a window of opportunity?
Dr.Marco Gambacciono, EMAS lecture at EBCOG, Antwerp, May 2010

 

Should osteoporosis prevention start at the menopause or should we only target women at high risk?
Prof.Marc Brincat, Dr.J.Calleja-Agius, EMAS lecture at EBCOG, Antwerp, May 2010

 

Making sense of HT after menopause: is there a place for HT in view of the stroke risk?
Prof.Serge Rozenberg, EMAS lecture at EBCOG, Antwerp, May 2010
 
Is postmenopause hormone therapy acceptable in view of breast cancer risk?
Dr.Irene Lambrinoudaki, EMAS lecture at EBCOG, Antwerp, May 2010
 
Managing women with premature ovarian failure
Dr.Svetlana Vujovic, Prof.Marc Brincat, Dr.Tamer Erel, Dr.Marco Gambacciani, Dr.Irene Lambrinoudaki, Dr.Mette H Moen, Dr.Karin Schenck-Gustafsson, Dr.Florence Tremollieres, Prof.Serge Rozenberg , Dr.Margaret Rees
 

Managing obese postmenopausal women
Dr.Irene Lambrinoudaki, Prof.Marc Brincat, Dr.Tamer Erel, Dr.Marco Gambacciani, Dr.Mette H Moen, Dr.Karin Schenck-Gustafsson, Dr.Florence Tremollieres, Dr.Svetlana Vujovic, Dr.Margaret Rees, Prof.Serge Rozenberg

 

Managing the Menopause in women with epilepsy
Dr.Tamer Erel, Prof.Marc Brincat, , Dr.Marco Gambacciani, Dr.Irene Lambrinoudaki, Dr.Mette H Moen, Dr.Karin Schenck-Gustafsson, Dr.Florence Tremollieres, Dr.Svetlana Vujovic, Prof.Serge Rozenberg, Dr.Margaret Rees

2009

Breast cancer, cardiovascular, and osteoporosis risk assessment in a 12 minute consultation

Managing Oestrogen Deficiency after Breast Cancer

Place of Hormone Therapy in Osteroporosis Management
Prof. M-P. Brincat and Dr.J.Calleja-Agius, Menopause Congress Vienna, December 2009

2008

Obesity, insulin resistance and breast cancer
Prof. Anne Gompel, Unité de Gynécologie, Hôtel-Dieu de Paris, University Paris Descartes, INSERM U673

Influence of progestin and androgen on breast cancer
Prof.AnneGompel,MD,PhDTreasurer of EMASINSERM U673, Unitéde GynécologieHôtel-Dieude

2006

EMAS 2006 Breast Course
Prof. Anne Gompel, Unité de Gynécologie, Hôtel-Dieu de Paris, University Paris Descartes, INSERM U673

 

Disclaimer: 

The information contained on this page has been submitted by the Author.  As such, the responsibility of content remains with the Author and is not an official statement from EMAS.

This material is to be used for educational purposes only and is not intended for commercial use.  No information may be copied or cited without prior consent from the Author.  The products mentioned are not necessarily endorsed by the Author.

For any further information, please contact the EMAS secretariat.

Back to Top
EMAS Online EMAS Online

© 2008 EMAS-ONLINE.ORG KENES INTERNATIONAL